{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T22:39:35Z","timestamp":1792881575970,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T00:00:00Z","timestamp":1730332800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1187743"],"award-info":[{"award-number":["GNT1187743"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Microbe"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.lanmic.2024.101038","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T09:21:55Z","timestamp":1743153715000},"page":"101038","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Establishing the lowest penicillin concentration to prevent pharyngitis due to Streptococcus pyogenes using a human challenge model (CHIPS): a randomised, double-blind, placebo-controlled trial"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5233-4438","authenticated-orcid":false,"given":"Thel K","family":"Hla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9432-6700","authenticated-orcid":false,"given":"Joshua","family":"Osowicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Salman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu","family":"Page-Sharp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7285-1953","authenticated-orcid":false,"given":"Okhee","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristy","family":"Azzopardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7101-0976","authenticated-orcid":false,"given":"Michael","family":"Morici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin T","family":"Batty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renae K","family":"Barr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie L","family":"Enkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3121-4397","authenticated-orcid":false,"given":"Joseph","family":"Kado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Hatchuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alma","family":"Fulurija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L","family":"Snelling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C","family":"Steer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Carapetis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4334-5351","authenticated-orcid":false,"given":"Laurens","family":"Manning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanmic.2024.101038_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.84","article-title":"Acute rheumatic\u00a0fever\u00a0and rheumatic heart disease","volume":"2","author":"Carapetis","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.lanmic.2024.101038_bib2","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019\u00a0Study","volume":"76","author":"Roth","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.lanmic.2024.101038_bib3","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1440-1754.2010.01942.x","article-title":"Rheumatic fever recurrence\u00a0prevention: a nurse-led programme of 28-day penicillin in\u00a0an area of high endemnicity","volume":"47","author":"Spinetto","year":"2011","journal-title":"J\u00a0Paediatr Child Health"},{"key":"10.1016\/j.lanmic.2024.101038_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/2395-5414.157554","article-title":"Evolution, evidence and effect of secondary prophylaxis against rheumatic fever","volume":"1","author":"Wyber","year":"2015","journal-title":"J\u00a0Pract Cardiovasc Sci"},{"key":"10.1016\/j.lanmic.2024.101038_bib5","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jama.1952.03680160021005","article-title":"Prophylaxis against group A streptococcal infections in rheumatic fever patients; use of new\u00a0repository penicillin preparation","volume":"150","author":"Stollerman","year":"1952","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.lanmic.2024.101038_bib6","first-page":"499","article-title":"N,N\u2032-dibenzylethylenediamine penicillin: preparation and properties","volume":"1","author":"Szabo","year":"1951","journal-title":"Antibiot Chemother (Northfield Ill)"},{"key":"10.1016\/j.lanmic.2024.101038_bib7","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1128\/AAC.38.5.1203","article-title":"Penicillin concentrations after increased doses of benzathine penicillin G\u00a0for prevention of secondary rheumatic fever","volume":"38","author":"Currie","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.lanmic.2024.101038_bib8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF02722027","article-title":"Sister-chromatid exchange analysis on long-term benzathine penicillin for secondary prophylaxis of rheumatic fever","volume":"68","author":"D\u00fcndar\u00f6z","year":"2001","journal-title":"Indian J\u00a0Pediatr"},{"key":"10.1016\/j.lanmic.2024.101038_bib9","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1093\/jac\/dkz076","article-title":"A\u00a0population pharmacokinetic study of benzathine benzylpenicillin G\u00a0administration in children and adolescents with rheumatic heart disease: new insights for improved secondary prophylaxis strategies","volume":"74","author":"Hand","year":"2019","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.lanmic.2024.101038_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009399","article-title":"High risk of early sub-therapeutic penicillin concentrations after intramuscular benzathine penicillin G\u00a0injections in Ethiopian children and adults\u00a0with rheumatic heart disease","volume":"15","author":"Ketema","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.lanmic.2024.101038_bib11","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/INF.0b013e31825051d4","article-title":"Factors associated with loss of penicillin G\u00a0concentrations in serum after intramuscular benzathine penicillin G\u00a0injection: a meta-analysis","volume":"31","author":"Broderick","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.lanmic.2024.101038_bib12","doi-asserted-by":"crossref","first-page":"6735","DOI":"10.1128\/AAC.02744-14","article-title":"A\u00a0population pharmacokinetic modeling approach shows that serum penicillin G\u00a0concentrations are below inhibitory concentrations by two weeks after benzathine penicillin G\u00a0injection in the majority of young adults","volume":"58","author":"Neely","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.lanmic.2024.101038_bib13","article-title":"How many doses make a difference? An analysis of secondary prevention of rheumatic fever and rheumatic heart disease","volume":"7","author":"de Dassel","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.lanmic.2024.101038_bib14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0022-3476(86)81009-5","article-title":"Rheumatic fever recurrences: controlled study of 3-week versus 4-week benzathine penicillin prevention programs","volume":"108","author":"Lue","year":"1986","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.lanmic.2024.101038_bib15","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/BF02019938","article-title":"Effects of subminimal inhibitory concentrations of chloramphenicol, erythromycin and penicillin on group A streptococci","volume":"1","author":"Michel","year":"1982","journal-title":"Eur J\u00a0Clin Microbiol"},{"key":"10.1016\/j.lanmic.2024.101038_bib16","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1128\/AAC.20.5.563","article-title":"Effect of subinhibitory concentrations of antibiotics on the adhesion of Streptococcus pyogenes to pharyngeal epithelial cells","volume":"20","author":"Tylewska","year":"1981","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.lanmic.2024.101038_bib18","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.gheart.2013.08.011","article-title":"Benzathine penicillin G for the management of RHD: concerns about quality and access, and opportunities for intervention and improvement","volume":"8","author":"Wyber","year":"2013","journal-title":"Glob Heart"},{"key":"10.1016\/j.lanmic.2024.101038_bib19","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s13346-016-0313-z","article-title":"Preliminary consultation on preferred product characteristics of benzathine penicillin G\u00a0for secondary prophylaxis of rheumatic fever","volume":"6","author":"Wyber","year":"2016","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.lanmic.2024.101038_bib20","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1016\/S2666-5247(20)30240-8","article-title":"A\u00a0controlled human infection model of Streptococcus pyogenes pharyngitis (CHIVAS-M75): an observational, dose-finding study","volume":"2","author":"Osowicki","year":"2021","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.lanmic.2024.101038_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-064022","article-title":"Study protocol for controlled human infection for penicillin G\u00a0against Streptococcus pyogenes: a double-blinded, placebo-controlled, randomised trial to determine the minimum concentration required to prevent experimental pharyngitis (the CHIPS trial)","volume":"12","author":"Hla","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.lanmic.2024.101038_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00647-18","article-title":"A\u00a0controlled human infection model of group A Streptococcus pharyngitis: which strain and why?","volume":"4","author":"Osowicki","year":"2019","journal-title":"MSphere"},{"key":"10.1016\/j.lanmic.2024.101038_bib23","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.jiac.2022.04.016","article-title":"Stability of benzylpenicillin for continuous intravenous infusions: an isotonic formulation for therapeutic use and a low-dose formulation for clinical trial","volume":"28","author":"Batty","year":"2022","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.lanmic.2024.101038_bib24","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1016\/j.vaccine.2019.03.059","article-title":"Controlled human infection for vaccination against Streptococcus pyogenes (CHIVAS): establishing a group A Streptococcus pharyngitis human infection study","volume":"37","author":"Osowicki","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.lanmic.2024.101038_bib25","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00252-17","article-title":"Penicillin dried blood spot assay for use in patients receiving intramuscular benzathine penicillin G\u00a0and other penicillin preparations to prevent rheumatic fever","volume":"61","author":"Page-Sharp","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.lanmic.2024.101038_bib26","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae272","article-title":"Serological responses to Streptococcus pyogenes vaccine candidate antigens suggests that Streptococcus dysgalactiae is the predominant cause of lower limb cellulitis","volume":"11","author":"Taggart","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.lanmic.2024.101038_bib27","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/bimj.201700211","article-title":"BMA-Mod: a Bayesian model averaging strategy for determining dose-response relationships in the presence of model uncertainty","volume":"61","author":"Gould","year":"2019","journal-title":"Biom J"},{"key":"10.1016\/j.lanmic.2024.101038_bib28","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1093\/jac\/dkaa282","volume":"75","author":"Kado","year":"2020","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.lanmic.2024.101038_bib29","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00962-23","article-title":"Subcutaneous infusion of high-dose benzathine penicillin G\u00a0is safe, tolerable, and suitable for less-frequent dosing for rheumatic heart disease secondary prophylaxis: a phase 1 open-label population pharmacokinetic study","volume":"67","author":"Kado","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.lanmic.2024.101038_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0285037","article-title":"Qualitative assessment of healthy volunteer experience receiving subcutaneous infusions of high-dose benzathine penicillin G (SCIP) provides insights into design of late phase clinical studies","volume":"18","author":"Enkel","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.lanmic.2024.101038_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0302493","article-title":"\u201cHurts less, lasts longer\u201d; a\u00a0qualitative study on experiences of young people receiving high-dose subcutaneous injections of benzathine penicillin G\u00a0to prevent rheumatic heart disease in New Zealand","volume":"19","author":"Cooper","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.lanmic.2024.101038_bib32","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/infdis\/138.6.712","article-title":"Protective studies with group A\u00a0streptococcal M\u00a0protein vaccine. III. Challenge of volunteers after systemic or intranasal immunization with type 3\u00a0or type 12\u00a0group A Streptococcus","volume":"138","author":"D\u2019Alessandri","year":"1978","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.lanmic.2024.101038_bib33","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1172\/JCI107372","article-title":"Protective study with a group A\u00a0streptococcal M\u00a0protein vaccine. Infectivity challenge of human volunteers","volume":"52","author":"Fox","year":"1973","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.lanmic.2024.101038_bib34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/infdis\/131.3.217","article-title":"Protective studies with a group A\u00a0streptococcal M\u00a0protein vaccine. II. Challange of volenteers after local immunization in the upper respiratory tract","volume":"131","author":"Polly","year":"1975","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.lanmic.2024.101038_bib35","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1086\/516375","article-title":"Why have group A streptococci remained susceptible to penicillin? Report on a symposium","volume":"26","author":"Horn","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lanmic.2024.101038_bib36","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00090-20","article-title":"Restricted sequence variation in Streptococcus pyogenes penicillin binding proteins","volume":"5","author":"Hayes","year":"2020","journal-title":"MSphere"}],"container-title":["The Lancet Microbe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666524724003069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666524724003069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T22:14:44Z","timestamp":1757628884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666524724003069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S2666524724003069"],"URL":"https:\/\/doi.org\/10.1016\/j.lanmic.2024.101038","relation":{},"ISSN":["2666-5247"],"issn-type":[{"value":"2666-5247","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Establishing the lowest penicillin concentration to prevent pharyngitis due to Streptococcus pyogenes using a human challenge model (CHIPS): a randomised, double-blind, placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Microbe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanmic.2024.101038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101038"}}